Atlas Trials

Predictive Immune Biomarkers for COVID-19 Pathogenesis

Clinical trial NCT04385108 · COMPLETED

Trial details

NCT number
NCT04385108
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2020-03-04
Primary completion
2020-12-31
Enrollment
565

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.